This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Shares Soar on Estee Lauder Report (Update)

Updated from 12:26 p.m. EDT.

Continuing the trend of cosmetic companies surprising investors with robust earnings, Estee Lauder (EL - Get Report) posted a better-than-expected profit in the third quarter, buoyed by strong sales in Asia.

The news sent the company's shares soaring more than 18% in afternoon trading to close at $36.88.

The maker of Clinique and M.A.C. cosmetics, the company said its earnings reached $27.2 million, or 14 cents a share, compared with $90.1 million, or 46 cents, a year earlier.

Excluding restructuring and other charges, earnings were 16 cents a share, far surpassing analysts' expected earnings of 5 cents.

Sales fell 10% to $1.70 billion, hurt by the strength of the U.S. dollar. A decline in passenger traffic through Estee Lauder's airport stores also cut away at its travel retail business, especially in Europe, the Middle East and Africa.

The company's fragrance line was especially hard hit across all regions, as consumers stayed away from designer fragrances.

Skin care sales have been the most steady, as consumers view these products more as necessities then discretionary purchases. This sentiment bodes well for Avon Products (AVP - Get Report), which tends to be a trade-down brand, sending shares up 7% to close at $25.22. The company reports earnings later in the week.

Estee Lauder is in the midst of a company overhaul under new CEO Fabrizio Freda. The company plans to cut jobs, freeze merit raises and maintain its hiring freeze under its four-year restructuring. Freda became president and CEO during the third quarter.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
AVP $7.02 1.59%
EL $90.22 0.97%
REV $37.09 -0.24%
AAPL $132.54 0.88%
FB $80.54 0.07%

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs